We are live on ! Find out more
JGBO

Jiangbo Pharmaceuticals, Inc. Common Stock
JGBO

Delisted

JGBO was delisted on the 31st of May, 2011.

Back to rankings

2 hedge funds and large institutions have $19K invested in Jiangbo Pharmaceuticals, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

63% less capital invested

Capital invested by funds: $52K → $19K (-$33K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

JGBO Hedge Fund Activity: Q3 2013 in Review

2 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Jiangbo Pharmaceuticals, Inc. Common Stock (JGBO) for Q3 2013, worth a combined $19K — down 63% from $52K a quarter earlier.

Fund positioning in JGBO was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Jiangbo Pharmaceuticals, Inc. Common Stock (JGBO) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $19K of Jiangbo Pharmaceuticals, Inc. Common Stock stock for Q3 2013, down 63% quarter-over-quarter.
  • 0 funds opened new Jiangbo Pharmaceuticals, Inc. Common Stock positions in Q3 2013 and 0 closed out.

Based on aggregated 13F filings for Q3 2013.